Premium
Inhibitors of mTOR pathway for cancer therapy, moving on from rapalogs to TORKinibs
Author(s) -
Owonikoko Taofeek K.
Publication year - 2015
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.29424
Subject(s) - medicine , pi3k/akt/mtor pathway , cancer , discovery and development of mtor inhibitors , cancer research , oncology , signal transduction , genetics , biology
Advancing cancer treatment through mTOR pathway inhibition has progressed from rapalogs to TORKinibs.